GlassScriptPhysician profile
Bryan M Lazzara
NPI 1033408836
$1,023.94
in general payments reported to CMS, 2019-2025
11 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2022: $120 · 2023: $226 · 2024: $355 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $191.18 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $189.15 | 2022-2025 | Clottriever Bold Catheter |
| Teleflex LLC | $144.52 | 2024 | |
| Boston Scientific Corporation | $121.43 | 2024 | Icefx Cryoablation System, Therasphere Y90 Glass Microspheres 10 Gbq, Obsidio |
| Silk Road Medical, INC. | $119.50 | 2019 | |
| Sirtex Medical INC | $88.83 | 2024 | Lava Les (Liquid Embolic System) |
| Relievant Medsystems, INC. | $61.13 | 2019 | |
| Medtronic, INC. | $41.92 | 2022-2023 | Abre |
| Terumo Medical Corporation | $26.49 | 2025 | Azur Cx Detachable |
| Penumbra, INC. | $25.91 | 2025 | Indigo System |
| Angiodynamics, INC. | $13.88 | 2023 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Lazzara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.